Bioburden testing is the method of calculating the load of microorganisms, in or on a medical instrument, raw material, packaged goods among others. The results from bioburden testing are used to determine the sterilization methods to be used while processing the material. Every measurement requires a definitive unit to quantify it; in bioburden testing the unit is CFU (Colony forming Units) per gram or per square centimeter.
Global bioburden testing market is projected to reach USD 907.4 million by 2024 from USD 452.6 million in 2016, at a CAGR of 9.1% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Request For Free Sample Report @: http://databridgemarketresearch.com/request-a-sample/?dbmr=bioburden-testing-market
The global bioburden testing market is segmented on the basis of test type, product type, technology, application, end-user, and geography.
On the basis of test type the bioburden testing market is segmented into aerobic, anaerobic, fungi and spore count. The global bioburden testing market segment is further categorized on the basis of product type into instruments and consumable. The instrument market segment is sub-segment into automated microbial identification systems, PCR (polymerase chain reaction), microscopes. The consumables market segment is sub segmented into kits, reagents and other consumables.
On the basis of technology microbial filter method, advanced colorimetric method and plate count method. The plate count method and membrane filtration method can be used to analyze the number of microbes in sample; the sample is passing through a filter with a pore size of 0.45 micrometers or less. Oldest methods for bioburden testing plate count method, however is not used frequently on a great scale commercial basis due to its time consuming procedure. Advanced colorimetric method is at the moment the most capable and widely used bioburden testing technology. The gathering of colorimeter and computational capabilities has enabled advanced colorimetric methods to deliver swift results of quantifying bioburden.
On the basis of End User the market is segmented into Pharmaceutical, Biotechnology, Industrial, and Food & Beverage.
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2017, North America is expected to dominate the bioburden market with 57.6% market share followed by Europe and APAC. However the APAC region is expected to grow at the highest CAGR of 17.4% in the forecast period 2017 to 2024
What this Research Study Offers:
1. Global bioburden testing market share assessments for the regional and country level segments
2. Global bioburden testing market share analysis of the top industry players
3. Strategic recommendations for the new entrants in global bioburden testing market.
4. Global bioburden testing market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional.
5. Global bioburden testing market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
6. Strategic recommendations in key business segments based on the global bioburden testing market estimations
7. Competitive landscaping mapping the key common trends
8. Company profiling with detailed strategies, financials, and recent developments
9. Supply chain trends mapping the latest technological advancements
Major Market Key Players:
The global bioburden testing market report contains an in-depth profiling of the key market players, along with the recent developments (innovative product launches, agreements, joint ventures, business and alliance) and strategies adopted by them to continue and build up their positions in the market. Some of the major players operating in this market are Charles, Pacific Bio labs, Inc., Sigma-Aldrich Corporation, SGS S.A., WuXi PharmaTech Inc., Becton, Dickinson and Company, Merck & Co., Inc., Charles River Laboratories International Inc., North American Science Associates, Inc. (NAMSA), Nelson Laboratories, Inc., Dynatec Labs, and ATS Labs, Inc. among others.
Purchase Full Report @ http://databridgemarketresearch.com/reports/bioburden-testing-market/
Global Transplant Diagnostics Market – Industry Trends and Forecast to 2024
Global Transplant Diagnostics Market By Technology (Molecular Assay Technologies (PCR-Based Molecular Assay Technologies (Real-Time PCR, SSP-PCR, SSO-PCR), Sequencing-Based Molecular Assay Technologies (Sanger, NGS)), Non-Molecular Assay Technologies), By Product type (Reagents & Consumables, Instruments, Software & Services), By Application (Diagnostic, Research), By End User (Hospitals & Transplant Centers, Commercial Service Providers, Research Laboratories and Academic Institutes), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024:
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar